CLINICAL_TRIALS
trial_result
· 2016-11-02
Clinical Trial Update: A Study of RO5045337 in Patients With Liposarcomas Prior to Debulking Surgery [Phase 1]
Summary
A Phase 1 study evaluating RO5045337 in patients with liposarcoma prior to debulking surgery has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Sarcoma | Phase 1 | Status: COMPLETED